BLUECHIIP LIMITED(BCT)

Shareholders in this company should consider crystallising a capital loss in 2025/26 by selling their shares. This process is now much easier and quicker. It can be achieved online by entering transaction details here. While, this usually makes good economic sense we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person.

delisted for non-payment of annual listing fee under Listing Rule 17.15

we understand the company failed and has not paid the annual listing fee

The company faced trading suspension on August 22, 2025, for failing to pay annual listing fees by August 21, 2025. The entity did not pay its annual listing fees for the year ending June 30, 2026.

Entities with securities suspended for over three months must lodge periodic reports, meet a 1 year deadline for the oldest outstanding report, and execute plans for resuming trading to ASX's satisfaction. Failure to meet deadlines results in removal from the official list.

The company's sale of assets was finalized, with no dividends or shareholder returns. The company was wound up without a DOCA proposal, and Manuel Hanna was appointed as the Liquidator. The Liquidator's Statutory Report to creditors will be issued in October 3 2025, providing updates on investigations and potential future recoveries.

The company plans to use the ASIC Corporations Instrument 2015/251 to defer financial reporting obligations for 6 to 24 months. This allows the company to avoid obligations related to a financial year or half-year, and avoids holding an Annual General Meeting.

Manuel Hanna issued a second report to creditors on 17 April 2025, outlining investigations and providing an opinion on the company's affairs. The report outlines the Administrator's investigations and the possibility of winding up the company. The Administrator is also actively pursuing a process for either asset sale or recapitalization via a deed of company arrangement. A further report will be issued before the reconvened meeting.

Entities that have been suspended for more than three months due to their unfiled periodic reports, along with the oldest overdue report deadline and their two-year deadline for trading plans, will be removed from the official list if these conditions are not fulfilled.

Manuel Hanna of Romanis Cant is appointed Administrator

The company's securities were suspended from quotation due to breach of Listing Rule 12.2, and will remain suspended until ASX determines compliance and reinstates them to quotation.

The company releases its results of its annual general meeting.

The company releases a letter to shareholders. Shareholders suspended until 2024 audited accounts and Annual Report lodged. Strategic Review focused on partnerships, re-financing, and investment. BioLife deal announced, sales revenue expected.

The company releases its Quarterly Activities and Quarterly Appendix 4C Cash Flow Report.

The entities suspended for over three months failed periodic reports, the oldest outstanding report deadline, and their 2 year deadline for trading plans. If not met, they will be removed from the official list, usually after the first trading day.

The Annual General Meeting will be held at 11:00am (AEDT) on 30 January 2025 at the Offices of Phillips Ormonde Fitzpatrick, Level 16, 333 Collins Street, Melbourne, VIC 3000.

The company has announced a strategic review and initiated an interim capital raising. The company has entered a partnership with BioLife Solutions and continues to build direct market sales to 38 labs across 18 customers. The company's annual meeting is set for January 2025.

The company has signed an exclusive license, development, and supply agreement with BioLife Solutions, a leading provider of bioproduction tools and services for Cell and Gene Therapy. BioLife will integrate Bluechiip's unique technology into its proprietary primary packaging containers, a significant milestone for Bluechiip, with potential for ongoing royalties and product sales.

The company has been granted an extension by ASIC, allowing it to hold its Annual General Meeting until January 31, 2025, after completing its strategic process.

The company lodges its Quarterly Activities & Appendix 4C Cash Flow Report.

The securities of the company will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Tuesday, 1 October 2024, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Monday, 30 September 2024, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed.

The suspension of trading in the securities of Bluechiip Limited will be lifted immediately, following the release by BCT of an announcement regarding a purported termination of a chip supply agreement with Labcon North America.

Labcon North America has provided notice to Bluechiip purporting to terminate the chip supply agreement it has with Bluechiip. Bluechiip considers that the termination is unlawful. Labcon has also asserted in its correspondence a claim for damages in the region of US$500,000 which Bluechiip categorically refutes. Negotiations with Labcon have now ceased and as a result Bluechiip has instructed its lawyers to pursue all rights and remedies available to it under the supply agreement, including, but not limited to, recovery from Labcon of an outstanding balance of US$3.5million which Bluechiip considers is now immediately due and payable.

The securities of Bluechiip Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of BCT, pending the release of an announcement regarding the outcome of the discussions with Labcon.

The suspension of trading in the securities of Bluechiip Limited (the "Company") will be lifted immediately, following the release of an announcement by the Company today. Security Code: BCT

The securities of Bluechiip Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement. Security Code: BCT

The securities of Viralytics Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement in relation to the outcome of a capital raising. Security Code: VLA

The securities of Bluechiip Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement. Security Code: BCT